过去一年中添加的文章，按日期排序
Polyphyllin I ameliorates gefitinib resistance and inhibits the VEGF/VEGFR2/p38 pathway by targeting HIF-1a in lung adenocarcinoma
D Zhang, X Tian, Y Wang, F Liu, J Zhang, H Wang… - Phytomedicine, 2024 - Elsevier
6 天前 - … Epidermal growth factor receptor tyrosine kinase … inevitable that resistance to
EGFR-TKIs therapy eventually arises. Polyphyllin I (PPI), derived from Paris polyphylla rhizomes, …
EGFR-TKIs therapy eventually arises. Polyphyllin I (PPI), derived from Paris polyphylla rhizomes, …
Synergistic Effects of Neratinib in Combination With Palbociclib or Miransertib in Brain Cancer Cells
E Mulliqi, S Khelwatty, A Morgan, K Ashkan… - World Journal of …, 2024 - wjon.org
7 天前 - … of epidermal growth factor receptor (EGFR) resulted in approval of several forms
of EGFR inhibitors in the treatment … of transcription (STAT3) inhibitor stattic, Abl/platelet-derived …
of EGFR inhibitors in the treatment … of transcription (STAT3) inhibitor stattic, Abl/platelet-derived …
A Saccharomyces Boulardii-Derived Antioxidant Protein, Thioredoxin, Ameliorates Intestinal Inflammation Through Transactivating Epidermal Growth Factor Receptor
X Qin, L Yang, Q Zhao, Q Zhao, W Li, J Wu… - … Growth Factor Receptor - papers.ssrn.com
7 天前 - … yeast for the treatment of gastrointestinal disorders, 30 … activation of epidermal
growth factor receptor (EGFR) in … this article were approved by the Institutional Animal Care 134 …
growth factor receptor (EGFR) in … this article were approved by the Institutional Animal Care 134 …
Hubungan Derajat Efek Samping Dermatologi Egfr-Tki Dengan Indeks Kualitas Hidup Dermatologi (Dlqi) Pada Pasien Kanker Paru Karsinoma Bukan Sel Kecil …
E Napitupulu - 2024 - etd.repository.ugm.ac.id
8 天前 - … Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR -TKI) drugs
are a main therapy for … Meanwhile, the degree of side effects was obtained from the doctor's …
are a main therapy for … Meanwhile, the degree of side effects was obtained from the doctor's …
… based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner …
KH Lue, YH Chen, SC Chu, CB Lin, TF Wang… - … of Nuclear Medicine, 2024 - Springer
9 天前 - … drivers, many targeted therapies have emerged to improve … Epidermal growth
factor receptor (EGFR) mutations are … that of the EGFR mutation type and 18 F-FDG PET-derived …
factor receptor (EGFR) mutations are … that of the EGFR mutation type and 18 F-FDG PET-derived …
Abstract PO2-06-08: Suppression of GATA2/3-FOXA1-HER3 Axis by Histone Deacetylase (HDAC) Inhibitors shows Antitumor Activity in Basal-like Breast Cancer
B Liu, C Tan, H Lyu - Cancer Research, 2024 - AACR
12 天前 - … epidermal growth factor receptor (EGFR), activating downstream signaling pathways
in BLBC cells. Treatment … Notably, the combination of HDACis with an EGFR inhibitor (…
in BLBC cells. Treatment … Notably, the combination of HDACis with an EGFR inhibitor (…
Molecular docking of ferulic acid analogue compounds against epidermal growth factor receptor as a potential therapy for breast cancer
DA Ainurrizma, J Ekowati, D Pebrianti… - Pharmacy …, 2024 - pharmacyeducation.fip.org
13 天前 - … ferulic acid derivatives have high potential as an anticancer through EGFR inhibition
in … acid had the best potential among other derivatives, which showed the lowest binding …
in … acid had the best potential among other derivatives, which showed the lowest binding …
[PDF][PDF] EGFR amplification and EGFRvIII predict and participate in TAT-Cx43
A Álvarez-Vázquez, L San-Segundo, P Cerveró-García… - 2024 - researchgate.net
14 天前 - … (EGFR inhibitor) was studied in patientderived GBM stem … reveal that epidermal
growth factor receptor (EGFR) ampli… EGFR inhibitor, and with TMZ, the standard treatment for …
growth factor receptor (EGFR) ampli… EGFR inhibitor, and with TMZ, the standard treatment for …
4-anilinoquinazoline derivatives as the first potent NOD1-RIPK2 signaling pathway inhibitors at the nanomolar range with potential anti-inflammatory activity
A BARCZYK, M RIVOAL, C DEVOS, X DEZITTER… - 2024 - chemrxiv.org
18 天前 - … -selective RIPK2 inhibitor and is well known as an EGFR inhibitor. … The RIPK2 324
selectivity vs EGFR and VEGFR is … kinase inhibitors would be interesting for the treatment of …
selectivity vs EGFR and VEGFR is … kinase inhibitors would be interesting for the treatment of …
Treatment Patterns and Clinical Outcomes in Patients With Egfr-Mutated Non-Small Cell Lung Cancer after Progression on Osimertinib
ND Robinson, ME Canavan, PL Zhan… - Available at SSRN … - papers.ssrn.com
19 天前 - … with advanced epidermal growth factor receptor (EGFR)… institutional review board
was obtained. Because the data … or amivantamab with EGFR inhibition may be superior to …
was obtained. Because the data … or amivantamab with EGFR inhibition may be superior to …